Publication:

Fibrolytic vaccination against ADAM12 reduces desmoplasia in preclinical pancreatic adenocarcinomas

Date

Date

Date
2024
Journal Article
Published version

Citations

Citation copied

Chen, J., Sobecki, M., Krzywinska, E., Thierry, K., Masmoudi, M., Nagarajan, S., Fan, Z., He, J., Ferapontova, I., Nelius, E., Seehusen, F., Gotthardt, D., Takeda, N., Sommer, L., Sexl, V., Münz, C., DeNardo, D., Hennino, A., & Stockmann, C. (2024). Fibrolytic vaccination against ADAM12 reduces desmoplasia in preclinical pancreatic adenocarcinomas. EMBO Molecular Medicine, 16(12), 3033–3056. https://doi.org/10.1038/s44321-024-00157-4

Abstract

Abstract

Abstract

A hallmark feature of pancreatic ductal adenocarcinoma (PDAC) is massive intratumoral fibrosis, designated as desmoplasia. Desmoplasia is characterized by the expansion of cancer-associated fibroblasts (CAFs) and a massive increase in extracellular matrix (ECM). During fibrogenesis, distinct genes become reactivated specifically in fibroblasts, e.g., the disintegrin metalloprotease, ADAM12. Previous studies have shown that immunotherapeutic ablation of ADAM12$^{+}$

Additional indexing

Creators (Authors)

  • Chen, Jing
    affiliation.icon.alt
  • Sobecki, Michal
    affiliation.icon.alt
  • Krzywinska, Ewelina
    affiliation.icon.alt
  • Thierry, Kevin
    affiliation.icon.alt
  • Masmoudi, Mélissa
    affiliation.icon.alt
  • Nagarajan, Shunmugam
    affiliation.icon.alt
  • Fan, Zheng
    affiliation.icon.alt
  • He, Jingyi
    affiliation.icon.alt
  • Ferapontova, Irina
    affiliation.icon.alt
  • Nelius, Eric
    affiliation.icon.alt
  • Seehusen, Frauke
    affiliation.icon.alt
  • Gotthardt, Dagmar
    affiliation.icon.alt
  • Takeda, Norihiko
    affiliation.icon.alt
  • Sommer, Lukas
    affiliation.icon.alt
  • Sexl, Veronika
    affiliation.icon.alt
  • Münz, Christian
    affiliation.icon.alt
  • DeNardo, David
    affiliation.icon.alt
  • Hennino, Ana
    affiliation.icon.alt
  • Stockmann, Christian
    affiliation.icon.alt

Journal/Series Title

Journal/Series Title

Journal/Series Title

Volume

Volume

Volume
16

Number

Number

Number
12

Page range/Item number

Page range/Item number

Page range/Item number
3033

Page end

Page end

Page end
3056

Item Type

Item Type

Item Type
Journal Article

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Language

Language

Language
English

Publication date

Publication date

Publication date
2024-10-30

Date available

Date available

Date available
2024-12-04

Publisher

Publisher

Publisher

ISSN or e-ISSN

ISSN or e-ISSN

ISSN or e-ISSN
1757-4676

OA Status

OA Status

OA Status
Gold

Free Access at

Free Access at

Free Access at
DOI

PubMed ID

PubMed ID

PubMed ID

Citations

Citation copied

Chen, J., Sobecki, M., Krzywinska, E., Thierry, K., Masmoudi, M., Nagarajan, S., Fan, Z., He, J., Ferapontova, I., Nelius, E., Seehusen, F., Gotthardt, D., Takeda, N., Sommer, L., Sexl, V., Münz, C., DeNardo, D., Hennino, A., & Stockmann, C. (2024). Fibrolytic vaccination against ADAM12 reduces desmoplasia in preclinical pancreatic adenocarcinomas. EMBO Molecular Medicine, 16(12), 3033–3056. https://doi.org/10.1038/s44321-024-00157-4

Gold Open Access
Loading...
Thumbnail Image

Files

Files

Files
Files available to download:1

Files

Files

Files
Files available to download:1
Loading...
Thumbnail Image